[Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].
D000328:Adult; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use*; D004357:Drug Synergism; D004576:Electromyography; D005542:Forearm; D006801:Humans; D008875:Middle Aged; D009043:Motor Activity; D010276:Parasympatholytics / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy*; D014785:Vision, Ocular
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Effekt einer kombinierten Behandlung von Parkinsonpatienten mit L-Dopa und einem Decarboxylasehemmer (Ro 4-4602). Quantitative Analyse der Bradykinesie mittels Reaktionszeitmessungen.